Cargando…

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer

BACKGROUND: Medullary thyroid cancer (MTC) cells are capable of secreting various tumor markers including calcitonin and carcinoembyronic antigen (CEA). The purpose of this study is to determine whether abnormal CEA levels may be used as a tumor marker to predict the severity of disease in MTC. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turkdogan, Sena, Forest, Véronique-Isabelle, Hier, Michael P., Tamilia, Michael, Florea, Anca, Payne, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142324/ https://www.ncbi.nlm.nih.gov/pubmed/30223887 http://dx.doi.org/10.1186/s40463-018-0303-x

Ejemplares similares

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
por: Sasson, Mark, et al.
Publicado: (2017)

Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.
por: Ishikawa, N., et al.
Publicado: (1976)

The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
por: Jooya, Alborz, et al.
Publicado: (2016)

The McGill Thyroid Nodule Score’s (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review
por: Khalife, Sarah, et al.
Publicado: (2016)

Localization of carcinoembryonic antigen in medullary thyroid carcinoma by immunofluorescent techniques.
por: Hamada, S., et al.
Publicado: (1977)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations
por: Alohali, Sama, et al.
Publicado: (2023)

BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
por: Silver, Jennifer A., et al.
Publicado: (2021)

Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves’ disease patients: a retrospective matched cohort study
por: You, Eunice, et al.
Publicado: (2019)

SAT560 A Case of Medullary Thyroid Carcinoma with Increasing Carcinoembryonic Antigen and Stable Calcitonin Levels
por: Youssef, Kerolos N, et al.
Publicado: (2023)

Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
por: Jozaghi, Yelda, et al.
Publicado: (2013)

Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
por: Hosseini, S., et al.
Publicado: (2016)

Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review
por: Hier, Jessica, et al.
Publicado: (2021)

Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2022)

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer
por: Bardet, Stéphane, et al.
Publicado: (2022)

A Case of Paraneoplastic Erythropoietin Secretion Secondary to Medullary Thyroid Cancer
por: Pare, Aurelie, et al.
Publicado: (2021)

Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma
por: Bojunga, J, et al.
Publicado: (2001)

Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma
por: Ukrani, Janta, et al.
Publicado: (2023)

The first Canadian experience with the Afirma® gene expression classifier test
por: Kay-Rivest, Emily, et al.
Publicado: (2017)

A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC)
por: Passos, Ioannis, et al.
Publicado: (2021)

Preoperative prediction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a Canadian single-Centre experience
por: Larouche, Vincent, et al.
Publicado: (2020)

Molecular mutations as a possible factor for determining extent of thyroid surgery
por: Krasner, Joshua R., et al.
Publicado: (2019)

Combining serum calcitonin, carcinoembryonic antigen, and neuron‐specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma
por: Ye, Liuqing, et al.
Publicado: (2020)

Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?
por: Hudson, Thomas J., et al.
Publicado: (2023)

Thyroidectomy for Graves’ Disease Predicts Postoperative Neck Hematoma and Hypocalcemia: A North American cohort study
por: Mohtashami, Sadaf, et al.
Publicado: (2021)

Characteristics of PTEN Mutation in Thyroid Tumours: A Retrospective Chart Review
por: Bandargal, Saruchi, et al.
Publicado: (2023)

The Difference in Clinical Behavior of Gene Fusions Involving RET/PTC Fusions and THADA/IGF2BP3 Fusions in Thyroid Nodules
por: Tali, George, et al.
Publicado: (2023)

Preoperative vocal cord paralysis and its association with malignant thyroid disease and other pathological features
por: Kay-Rivest, Emily, et al.
Publicado: (2015)

Coexisting Molecular Alterations Increase the Risk of Malignancy in Thyroid Nodules with Copy Number Alterations
por: Rajab, Mohannad, et al.
Publicado: (2022)

EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles
por: Elsherbini, Noha, et al.
Publicado: (2022)

The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer
por: Wang, Lei, et al.
Publicado: (2021)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)

Completion thyroidectomy: predicting bilateral disease
por: Ibrahim, Badr, et al.
Publicado: (2015)

Carcinoembryonic Antigen Level Can be Overestimated in Metabolic Syndrome
por: Kim, Kyu-Nam, et al.
Publicado: (2011)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Pyogenic Liver Abscesses with an Elevated Carcinoembryonic Antigen Level
por: Huang, Yao-Kang, et al.
Publicado: (2022)

Carcinoembryonic Antigen in Whole Serum
por: MacSween, J. M., et al.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_s471b65pmom3nf3nct0tp6rofn